LABCORP HOLDINGS INC. Other Significant Noncash Transaction, Value of Consideration Given
LABCORP HOLDINGS INC. (LH) reported Other Significant Noncash Transaction, Value of Consideration Given of $25.10 million for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-10-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1 · last filed 2019-10-31
- LABCORP HOLDINGS INC. other significant noncash transaction, value of consideration given for the quarter ending 2019-09-30 was $25.10M, a 2.87% increase year-over-year.
- LABCORP HOLDINGS INC. other significant noncash transaction, value of consideration given for the quarter ending 2019-06-30 was $9.20M, a 36.99% decline year-over-year.
- LABCORP HOLDINGS INC. other significant noncash transaction, value of consideration given for the quarter ending 2019-03-31 was $24.70M, a 13.03% decline year-over-year.
- LABCORP HOLDINGS INC. other significant noncash transaction, value of consideration given for the quarter ending 2018-09-30 was $24.40M, a 27.81% decline year-over-year.
| Period end | Other Significant Noncash Transaction, Value of Consideration Given 3 month | Other Significant Noncash Transaction, Value of Consideration Given 3 month as first filed | Other Significant Noncash Transaction, Value of Consideration Given 6 month | Other Significant Noncash Transaction, Value of Consideration Given 6 month as first filed | Other Significant Noncash Transaction, Value of Consideration Given 9 month | Other Significant Noncash Transaction, Value of Consideration Given 9 month as first filed |
|---|---|---|---|---|---|---|
| 2019-09-30 | $25.10M 10-Q · filed 2019-10-31 | $34.30M derived: sum of 2 quarters · filed 2019-10-31 | $59.00M derived: sum of 3 quarters · filed 2019-10-31 | |||
| 2019-06-30 | $9.20M 10-Q · filed 2019-10-31 | $33.90M derived: sum of 2 quarters · filed 2019-10-31 | ||||
| 2019-03-31 | $24.70M 10-Q · filed 2019-10-31 | |||||
| 2018-09-30 | $24.40M 10-Q · filed 2019-10-31 | $39.00M derived: sum of 2 quarters · filed 2019-10-31 | $67.40M 10-Q · filed 2018-10-30 | |||
| 2018-06-30 | $14.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $43.00M 10-Q · filed 2018-07-27 | ||||
| 2018-03-31 | $28.40M 10-Q · filed 2018-05-01 | |||||
| 2017-09-30 | $33.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $38.20M derived: sum of 2 quarters · filed 2017-11-02 | $65.20M 10-Q · filed 2017-11-02 | |||
| 2017-06-30 | $4.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $31.40M 10-Q · filed 2017-08-02 | ||||
| 2017-03-31 | $27.00M 10-Q · filed 2017-04-28 | |||||
| 2016-09-30 | $26.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $55.50M derived: sum of 2 quarters · filed 2016-10-28 | $67.40M 10-Q · filed 2016-10-28 | |||
| 2016-06-30 | $28.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $40.70M 10-Q · filed 2016-07-29 | ||||
| 2016-03-31 | $11.90M 10-Q · filed 2017-04-28 | |||||
| 2015-09-30 | $30.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $55.70M derived: sum of 2 quarters · filed 2016-10-28 | $88.90M 10-Q · filed 2016-10-28 | $1.76B 10-Q · filed 2015-10-30 | ||
| 2015-06-30 | $25.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $58.80M 10-Q · filed 2016-07-29 | $1.76B 10-Q · filed 2015-07-30 | |||
| 2015-03-31 | $33.20M 10-Q · filed 2016-05-06 | $1.76B 10-Q · filed 2015-05-04 | ||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | $0.00 derived: sum of 2 quarters · filed 2015-10-30 | $0.00 10-Q · filed 2015-10-30 | |||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $0.00 10-Q · filed 2015-07-30 | ||||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |